Thomas DeLeon

Cholangiocarcinoma With <i>FGFR</i> Genetic Aberrations: A Unique Clinical Phenotype

Apurva Jain, Mitesh J. Borad, Robin Kate Kelley et al. · JCO Precision Oncology · 2018 · 163 citations

Pilot evaluation of PD-1 inhibition in metastatic cancer patients with a history of liver transplantation: the Mayo Clinic experience

Thomas DeLeon, Marcela Salomao, Bashar Aqel et al. · Journal of Gastrointestinal Oncology · 2018 · 150 citations · Full text

Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis

Ahmad H. Ali, James H. Tabibian, Navine Nasser‐Ghodsi et al. · Hepatology · 2017 · 128 citations

Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutations

Thomas DeLeon, Daniel Almquist, Benjamin R. Kipp et al. · PLoS ONE · 2020 · 31 citations · Full text

A pilot study of Pan-FGFR inhibitor ponatinib in patients with FGFR-altered advanced cholangiocarcinoma

Daniel H. Ahn, Pedro Luiz Serrano Usón, Peter Masci et al. · Investigational New Drugs · 2021 · 27 citations

Surgical Oncology, Oncology, Medicine +9